Funding for this research was provided by:
Bank of Canada (OPP1105071)
National Institutes for Allergy and Infectious Diseases (P30 AI027763 and K24 AI134413)
Received: 29 June 2020
Accepted: 30 September 2020
First Online: 16 October 2020
Ethics approval and consent to participate
: Ethical approval was granted by the University of Zambia Biomedical Research Ethics Committee, the University of Alabama at Birmingham and the Zambian Ministry of Health (Institutional Review Board No. 00001131 & Ref. No. 004–06-14). All participants provided written consent prior to participating.
: Not applicable.
: No potential conflict of interest was reported by the authors.